This effect was reversible by pharmacologic inhibition of TGF-β1 signalling in leukemia xenograft mouse models [115], indicating a potential therapeutic role of TGF-β1 blockade as already shown in other cancer entities [132, 133]. Here, TGFB1 is linked to leukemia.